Pilot will explore how AI-powered precision care can help operationalize emerging care delivery models by bringing patient-specific intelligence directly into clinician workflows.

PALO ALTO, Calif., Sept. 17, 2026 /PRNewswire/ — GW RhythmX, the AI-powered precision care and patient engagement company, today announced that Sentara Health has selected the company for a pilot initiative focused on advancing the future of primary care through real-time, patient-specific clinical intelligence.

The pilot will explore how clinicians can use AI-powered precision care technology to access relevant clinical, operational, and patient-specific insights at the point of care, helping care teams deliver more personalized, proactive, and coordinated care while reducing the administrative burden associated with navigating fragmented sources of information.

Healthcare systems across the country are redesigning primary care in response to growing patient demand, clinician shortages, increasing patient complexity, and rising expectations around access and outcomes. New models increasingly rely on team-based care, expanded use of advanced practice providers, an expanded care delivery team that includes RNs, pharmacists, and community health coaches, virtual care, and technology-enabled workflows to extend clinical capacity while maintaining high-quality, personalized care.

GW RhythmX was created to help operationalize these next-generation models. Its Precision Care Platform analyzes patient history, evidence-based guidelines, care gaps, social and financial determinants, payer requirements, formulary considerations, and other relevant clinical data to surface personalized recommendations during the patient encounter. The result is actionable intelligence delivered while care decisions are being made rather than after the fact. The comprehensive personalized data contained within the RhythmX AI platform will also enable more precise navigation and orchestration of care delivery leading to improved access.

“Healthcare is reaching an inflection point,” said Deepthi Bathina, CEO and founder of GW RhythmX. “Health systems are redesigning care models to improve access, support increasingly complex patient populations, and empower clinicians to practice at the top of their licenses. The challenge is ensuring those models can be consistently executed across every patient encounter. We believe AI-powered precision care can help bridge the gap between strategy and execution by delivering the right intelligence to the right clinician at the right moment.”

Bathina added, “The future of healthcare will be defined by how effectively we embed intelligence from clinical, operational, financial, and social data directly into care delivery workflows. Our vision is to help health systems move from fragmented information to coordinated action that improves both clinician and patient experiences.”

The pilot builds on GW RhythmX’s growing momentum as health systems seek to move beyond administrative AI toward solutions that support real-time clinical decision-making. Following the launch of RhythmX Pulse within Microsoft Marketplace and Dragon Copilot, GW RhythmX continues to work with healthcare organizations pursuing more personalized and scalable models of care delivery.

“Health systems are actively exploring innovative approaches to care delivery that can improve access, efficiency and patient outcomes,” said Prasanna Mohanty, EVP & President, Ambulatory Care, Sentara Health. “Technology has an important role to play in supporting clinicians and care teams as these models evolve. We look forward to evaluating how AI-powered precision care can help bring relevant patient information and clinical intelligence into workflows at the point of care.”

About GW RhythmX

Get Well and RhythmX AI have merged to form GW RhythmX, a new category of AI-powered Precision Care and patient engagement. The company pairs its clinical recommendation technology with established patient engagement infrastructure to help health systems deliver the right care, at the right time, through the right clinician and channel. Its solutions are deployed across more than 150 health systems, reaching over 85 million patients, including 8 million U.S. military veterans. GW RhythmX’s solutions were recognized in 2024 by KLAS Research, Fierce Healthcare, and AVIA Marketplace. A SymphonyAI Group company, GW RhythmX draws on more than $1 billion in R&D investment and longitudinal data spanning 300 million patients, 4.4 billion annual claims, and 1.8 million healthcare professionals across more than 3,000 facilities globally.

Chris Gale, Chris@GaleStrategies.com

View original content:https://www.prnewswire.com/news-releases/sentara-health-selects-gw-rhythmx-to-advance-the-next-era-of-primary-care-302881445.html

SOURCE GW RhythmX